Open AccessEfficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study
Author(s) -
Domenico Merante,
Julio Rosenstock,
Uma Sharma,
Karen Feins,
Ching Hsu,
Aaron I. Vinik
Publication year - 2017
Publication title -
pain medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 97
eISSN - 1526-4637
pISSN - 1526-2375
DOI - 10.1093/pm/pnw342
Subject(s) - medicine , placebo , pregabalin , neuropathic pain , brief pain inventory , anesthesia , adverse effect , diabetes mellitus , clinical endpoint , clinical trial , physical therapy , chronic pain , endocrinology , alternative medicine , pathology
To evaluate the effects of mirogabalin on patient-reported pain and sleep interference in diabetic peripheral neuropathic pain (DPNP).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom